BPG is committed to discovery and dissemination of knowledge
Articles Published Processes
5/26/2021 8:55:40 AM | Browse: 402 | Download: 1314
 |
Received |
|
2020-12-24 22:14 |
|
Peer-Review Started |
|
2020-12-24 22:15 |
 |
To Make the First Decision |
|
|
|
Return for Revision |
|
2021-02-17 11:30 |
|
Revised |
|
2021-02-26 12:40 |
|
Second Decision |
|
2021-04-22 07:41 |
|
Accepted by Journal Editor-in-Chief |
|
|
|
Accepted by Executive Editor-in-Chief |
|
2021-04-22 12:10 |
|
Articles in Press |
|
2021-04-22 12:10 |
|
Publication Fee Transferred |
|
|
|
Edit the Manuscript by Language Editor |
|
|
|
Typeset the Manuscript |
|
2021-05-20 14:25 |
|
Publish the Manuscript Online |
|
2021-05-26 08:55 |
| ISSN |
1948-0210 (online) |
| Open Access |
This article is an open-access article that was selected by an in-house editor and fully peer-reviewed by external reviewers. It is distributed in accordance with the Creative Commons Attribution NonCommercial (CC BY-NC 4.0) license, which permits others to distribute, remix, adapt, build upon this work non-commercially, and license their derivative works on different terms, provided the original work is properly cited and the use is non-commercial. See: http://creativecommons.org/Licenses/by-nc/4.0/ |
| Copyright |
© The Author(s) 2021. Published by Baishideng Publishing Group Inc. All rights reserved. |
| Article Reprints |
For details, please visit: http://www.wjgnet.com/bpg/gerinfo/247
|
| Permissions |
For details, please visit: http://www.wjgnet.com/bpg/gerinfo/207
|
| Publisher |
Baishideng Publishing Group Inc, 7041 Koll Center Parkway, Suite 160, Pleasanton, CA 94566, USA |
| Website |
http://www.wjgnet.com |
| Category |
Neurosciences |
| Manuscript Type |
Retrospective Study |
| Article Title |
Feasibility of allogeneic mesenchymal stem cells in pediatric hypoxic-ischemic encephalopathy: Phase I study
|
| Manuscript Source |
Invited Manuscript |
| All Author List |
Serdar Kabatas, Erdinç Civelek, Eyüp Can Savrunlu, Necati Kaplan, Osman Boyalı, Furkan Diren, Halil Can, Ali Genç, Tunç Akkoc and Erdal Karaöz |
| ORCID |
|
| Funding Agency and Grant Number |
|
| Corresponding Author |
Serdar Kabatas, MD, Full Professor, Department of Neurosurgery, University of Health Sciences, Gaziosmanpaşa Training and Research Hospital, Karayolları Mahallesi, Osmanbey Caddesi 616. Sokak No. 10, Gaziosmanpaşa, Istanbul 34255, Türkiye. kabatasserdar@hotmail.com |
| Key Words |
Hypoxic-ischemic encephalopathy; Pediatric; Stem cell; Wharton jelly |
| Core Tip |
Hypoxic-ischemic encephalopathy (HIE) emerges as one of the leading causes of morbidity and mortality in children. There are a limited number of options for treating HIE. Recently, stem cell and cellular therapies appear to be a potential treatment option for ischemic brain injury caused by HIE. The aim of this phase I open-label clinical study is to investigate the efficacy and safety of one of these stem cell-based therapies in a group of pediatric patients with HIE. Both the triple-route and multiple Wharton`s jelly-derived mesenchymal stem cells administrations were safe and effective in pediatric patients with HIE with significant neurological and functional improvements. |
| Publish Date |
2021-05-26 08:55 |
| Citation |
Kabatas S, Civelek E, Savrunlu EC, Kaplan N, Boyalı O, Diren F, Can H, Genç A, Akkoç T, Karaöz E. Feasibility of allogeneic mesenchymal stem cells in pediatric hypoxic-ischemic encephalopathy: Phase I study. World J Stem Cells 2021; 13(5): 470-484 |
| URL |
https://www.wjgnet.com/1948-0210/full/v13/i5/470.htm |
| DOI |
https://dx.doi.org/10.4252/wjsc.v13.i5.470 |
© 2004-2025 Baishideng Publishing Group Inc. All rights reserved. 7041 Koll Center Parkway, Suite 160, Pleasanton, CA 94566, USA
California Corporate Number: 3537345
